Isaac Blech - Net Worth and Insider Trading

Isaac Blech Net Worth

The estimated net worth of Isaac Blech is at least $0 dollars as of 2024-12-01. Isaac Blech is the Director of ContraFect Corp and owns about 20 shares of ContraFect Corp (CFRXQ) stock worth over $0. Details can be seen in Isaac Blech's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Isaac Blech has not made any transactions after 2017-07-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Isaac Blech

Isaac Blech Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Isaac Blech owns 10 companies in total, including ContraFect Corp (CFRXQ) , PDS Biotechnology Corp (PDSB) , and X4 Pharmaceuticals Inc (XFOR) among others .

Click here to see the complete history of Isaac Blech’s form 4 insider trades.

Insider Ownership Summary of Isaac Blech

Ticker	Comapny	Transaction Date	Type of Owner
CFRXQ	ContraFect Corp	2017-07-25	director
PDSB	PDS Biotechnology Corp	2016-06-21	director
XFOR	X4 Pharmaceuticals Inc	2019-03-13	director
		2015-10-14	director & 10 percent owner
		2018-08-13	director
		2017-11-22	director
		2016-12-07	director
		2014-01-07	director
		2016-07-22	director & 10 percent owner
		2016-04-15	director

Isaac Blech Latest Holdings Summary

Isaac Blech currently owns a total of 1 stock. Isaac Blech owns 20 shares of ContraFect Corp (CFRXQ) as of July 25, 2017, with a value of $0.

Latest Holdings of Isaac Blech

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
CFRXQ	ContraFect Corp	2017-07-25	20	0.00	0

Holding Weightings of Isaac Blech

Isaac Blech Form 4 Trading Tracker

According to the SEC Form 4 filings, Isaac Blech has made a total of 0 transactions in ContraFect Corp (CFRXQ) over the past 5 years. The most-recent trade in ContraFect Corp is the acquisition of 20 shares on July 25, 2017, which cost Isaac Blech around $19,840.

Insider Trading History of Isaac Blech

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Isaac Blech Trading Performance

GuruFocus tracks the stock performance after each of Isaac Blech's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Isaac Blech is -19.2%. GuruFocus also compares Isaac Blech's trading performance to market benchmark return within the same time period. The performance of stocks bought by Isaac Blech within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Isaac Blech's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Isaac Blech

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-8
Relative Return to S&P 500(%)	-6.62

Isaac Blech Ownership Network

Ownership Network List of Isaac Blech

No Data

Ownership Network Relation of Isaac Blech

Isaac Blech Owned Company Details

What does ContraFect Corp do?

Who are the key executives at ContraFect Corp?

Isaac Blech is the director of ContraFect Corp. Other key executives at ContraFect Corp include VP Finance Michael Messinger , General Counsel Natalie Bogdanos , and Chief Medical Officer Cara M Cassino .

ContraFect Corp (CFRXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ContraFect Corp (CFRXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ContraFect Corp (CFRXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ContraFect Corp (CFRXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

ContraFect Corp Insider Transactions

No Available Data

What does PDS Biotechnology Corp do?

Who are the key executives at PDS Biotechnology Corp?

Isaac Blech is the director of PDS Biotechnology Corp. Other key executives at PDS Biotechnology Corp include Senior VP & General Counsel Spencer D. Brown , Chief Financial Officer Matthew C Hill , and director & 10 percent owner Delyle W Bloomquist .

PDS Biotechnology Corp (PDSB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PDS Biotechnology Corp (PDSB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDS Biotechnology Corp (PDSB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PDS Biotechnology Corp (PDSB)'s detailed insider trading history can be found in Insider Trading Tracker table.

PDS Biotechnology Corp Insider Transactions

No Available Data

What does X4 Pharmaceuticals Inc do?

Who are the key executives at X4 Pharmaceuticals Inc?

Isaac Blech is the director of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include director & President and CEO Paula Ragan , Chief Scientific Officer Arthur Taveras , and Chief Operating Officer Mary Dibiase .

X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary

Over the past 18 months, Isaac Blech made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 627,488 shares made by Paula Ragan , a net sale of 161,480 shares made by Mary Dibiase , and a net sale of 552,345 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 692,259 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 692,259 shares. During the past 18 months, 1,652,390 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,627,390 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

X4 Pharmaceuticals Inc Insider Transactions

No Available Data

What does Avalo Therapeutics Inc do?

Who are the key executives at Avalo Therapeutics Inc?

Isaac Blech is the director & 10 percent owner of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .

Avalo Therapeutics Inc (AVTX) Insider Trades Summary

Over the past 18 months, Isaac Blech made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 31,325 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .

In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 1,000 shares, with a net purchase of 1,000 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 1,149 shares were bought by its insiders, resulting in a net sale of 14,199 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avalo Therapeutics Inc Insider Transactions

No Available Data

What does Aridis Pharmaceuticals Inc do?

Who are the key executives at Aridis Pharmaceuticals Inc?

Isaac Blech is the director of Aridis Pharmaceuticals Inc. Other key executives at Aridis Pharmaceuticals Inc include director & 10 percent owner & CEO & CSO & Director Vu Truong , director & 10 percent owner Eric Patzer , and 10 percent owner Fibrosis Foundation Cystic .

Aridis Pharmaceuticals Inc (ARDS) Insider Trades Summary

Over the past 18 months, Isaac Blech made no insider transaction in Aridis Pharmaceuticals Inc (ARDS). Other recent insider transactions involving Aridis Pharmaceuticals Inc (ARDS) include a net purchase of 714,286 shares made by Vu Truong , and a net purchase of 714,286 shares made by Eric Patzer .

In summary, during the past 3 months, insiders sold 0 shares of Aridis Pharmaceuticals Inc (ARDS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aridis Pharmaceuticals Inc (ARDS) were sold and 1,428,572 shares were bought by its insiders, resulting in a net purchase of 1,428,572 shares.

Aridis Pharmaceuticals Inc (ARDS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aridis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Adhera Therapeutics Inc do?

Who are the key executives at Adhera Therapeutics Inc?

Isaac Blech is the director of Adhera Therapeutics Inc. Other key executives at Adhera Therapeutics Inc include director & Chief Executive Officer Andrew Albert Kucharchuk , SVP Finance & Accounting Rhonda L. Stanley , and Chief Financial Officer Robert Eric Teague .

Adhera Therapeutics Inc (ATRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adhera Therapeutics Inc (ATRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adhera Therapeutics Inc (ATRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adhera Therapeutics Inc (ATRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adhera Therapeutics Inc Insider Transactions

No Available Data

What does InspireMD Inc do?

Who are the key executives at InspireMD Inc?

Isaac Blech is the director of InspireMD Inc. Other key executives at InspireMD Inc include EVP Clinical/Medical Affairs Patrick Verta , Chief Operating Officer Andrea Tommasoli , and VP Global Marketing Shane Thomas Gleason .

InspireMD Inc (NSPR) Insider Trades Summary

Over the past 18 months, Isaac Blech made no insider transaction in InspireMD Inc (NSPR). Other recent insider transactions involving InspireMD Inc (NSPR) include a net purchase of 50,000 shares made by Gary S Roubin ,

In summary, during the past 3 months, insiders sold 0 shares of InspireMD Inc (NSPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InspireMD Inc (NSPR) were sold and 50,000 shares were bought by its insiders, resulting in a net purchase of 50,000 shares.

InspireMD Inc (NSPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

InspireMD Inc Insider Transactions

No Available Data

What does CervoMed Inc do?

Who are the key executives at CervoMed Inc?

Isaac Blech is the director of CervoMed Inc. Other key executives at CervoMed Inc include GC & Secretary William Robert Elder , director & 10 percent owner Sylvie Gregoire , and Chief Financial Officer John William Tanner .

CervoMed Inc (CRVO) Insider Trades Summary

Over the past 18 months, Isaac Blech made no insider transaction in CervoMed Inc (CRVO). Other recent insider transactions involving CervoMed Inc (CRVO) include a net purchase of 1,000 shares made by William Robert Elder ,

In summary, during the past 3 months, insiders sold 0 shares of CervoMed Inc (CRVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CervoMed Inc (CRVO) were sold and 1,000 shares were bought by its insiders, resulting in a net purchase of 1,000 shares.

CervoMed Inc (CRVO)'s detailed insider trading history can be found in Insider Trading Tracker table.

CervoMed Inc Insider Transactions

No Available Data

What does root9B Holdings Inc do?

Who are the key executives at root9B Holdings Inc?

Isaac Blech is the director & 10 percent owner of root9B Holdings Inc. Other key executives at root9B Holdings Inc include director & CEO and Chairman Grano Joseph J Jr , CFO William Hoke , and 10 percent owner River Charitable Remainder Unitrust F/b/o Isaac Blech .

root9B Holdings Inc (RTNB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of root9B Holdings Inc (RTNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of root9B Holdings Inc (RTNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

root9B Holdings Inc (RTNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

root9B Holdings Inc Insider Transactions

No Available Data

What does Aevi Genomic Medicine Inc do?

Who are the key executives at Aevi Genomic Medicine Inc?

Isaac Blech is the director of Aevi Genomic Medicine Inc. Other key executives at Aevi Genomic Medicine Inc include director & Chief Executive Officer Michael F Cola , Chief Scientific Officer Garry Arthur Neil , and 10 percent owner Plc Astrazeneca .

Aevi Genomic Medicine Inc (GNMX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aevi Genomic Medicine Inc (GNMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aevi Genomic Medicine Inc (GNMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aevi Genomic Medicine Inc (GNMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aevi Genomic Medicine Inc Insider Transactions

No Available Data

Isaac Blech Mailing Address

Above is the net worth, insider trading, and ownership report for Isaac Blech. You might contact Isaac Blech via mailing address: C/o Inspiremd, Inc., 321 Columbus Avenue, Boston Ma 02116.

Discussions on Isaac Blech

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.